Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 18.4519.7712.44

What is the latest Core EBITDA Margin ratio of TRIDENT LIFELINE ?

The latest Core EBITDA Margin ratio of TRIDENT LIFELINE is 18.45 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202418.45
Mar202319.77
Mar202212.44

How is Core EBITDA Margin of TRIDENT LIFELINE Trending?

Years Core EBITDA Margin % Change
Mar2024 18.45
-6.68
Mar2023 19.77
58.92
Mar2022 12.44 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Core EBITDA Margin ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹286.9 Cr -7% -7.3% 24.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 3.9% -3.2% 3.1% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 1.8% -4.5% 53.9% Stock Analytics
CIPLA ₹117,415.0 Cr -0.6% -0.3% -2.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 1.2% -3% 14.9% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -3% -9.5% -11.7% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

-7%

-7.3%

24.2%

SENSEX

0.4%

-4.9%

-0.1%


You may also like the below Video Courses